Psychedelic Pharmaceutical Company MindMed Develops LSD Neutralizer Technology To Shorten & Stop LSD Trips

Mind Medicine (MindMed) Inc. in collaboration with University Hospital Basel’s Liechti Laboratory, has discovered and filed a patent application in the United States (preserving all worldwide rights) for a neutralizer technology intended to shorten and stop the effects of an LSD trip during a therapy session. This discovery, when further developed, may act as the ‘off-switch’ to an LSD trip.

MindMed is a psychedelic pharmaceutical company; the Liechti Laboratory is a leading research center focused on the pharmacology of psychedelic substances. This is the latest discovery based on surprising experimental results from work and collaboration conducted at the . . .